Rainer M Erdtmann - Net Worth and Insider Trading
Rainer M Erdtmann Net Worth
The estimated net worth of Rainer M Erdtmann is at least $20 Million dollars as of 2024-06-09. Rainer M Erdtmann is the President & COO, 10% Owner of Biomea Fusion Inc and owns about 4,922,191 shares of Biomea Fusion Inc (BMEA) stock worth over $20 Million. Rainer M Erdtmann is also the Director of Regenetp Inc and owns about 2,000 shares of Regenetp Inc (RGTPQ) stock worth over $284. Details can be seen in Rainer M Erdtmann's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Rainer M Erdtmann has not made any transactions after 2021-08-23 and currently still holds the listed stock(s).
Transaction Summary of Rainer M Erdtmann
Rainer M Erdtmann Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rainer M Erdtmann owns 3 companies in total, including Summit Therapeutics Inc (SMMT) , Regenetp Inc (RGTPQ) , and Biomea Fusion Inc (BMEA) .
Click here to see the complete history of Rainer M Erdtmann’s form 4 insider trades.
Insider Ownership Summary of Rainer M Erdtmann
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SMMT | Summit Therapeutics Inc | 2020-09-18 | director |
| RGTPQ | Regenetp Inc | 2019-12-16 | director |
| BMEA | Biomea Fusion Inc | 2021-08-23 | director & 10 percent owner & President and COO |
Rainer M Erdtmann Latest Holdings Summary
Rainer M Erdtmann currently owns a total of 2 stocks. Among these stocks, Rainer M Erdtmann owns 4,922,191 shares of Biomea Fusion Inc (BMEA) as of August 23, 2021, with a value of $20 Million and a weighting of 100%. Rainer M Erdtmann also owns 2,000 shares of Regenetp Inc (RGTPQ) as of December 16, 2019, with a value of $284 and a weighting of 0%.
Latest Holdings of Rainer M Erdtmann
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BMEA | Biomea Fusion Inc | 2021-08-23 | 4,922,191 | 4.14 | 20,377,871 |
| RGTPQ | Regenetp Inc | 2019-12-16 | 2,000 | 0.14 | 284 |
Holding Weightings of Rainer M Erdtmann
Rainer M Erdtmann Form 4 Trading Tracker
According to the SEC Form 4 filings, Rainer M Erdtmann has made a total of 3 transactions in Biomea Fusion Inc (BMEA) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Biomea Fusion Inc is the acquisition of 24,000 shares on August 23, 2021, which cost Rainer M Erdtmann around $316,800.
According to the SEC Form 4 filings, Rainer M Erdtmann has made a total of 1 transactions in Regenetp Inc (RGTPQ) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Regenetp Inc is the sale of 1,274 shares on December 16, 2019, which brought Rainer M Erdtmann around $78,660.
Insider Trading History of Rainer M Erdtmann
- 1
Rainer M Erdtmann Trading Performance
GuruFocus tracks the stock performance after each of Rainer M Erdtmann's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rainer M Erdtmann is -7.92%. GuruFocus also compares Rainer M Erdtmann's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rainer M Erdtmann within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Rainer M Erdtmann's insider trading performs compared to the benchmark.
Performance of Rainer M Erdtmann
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -12.56 | | | | | |
| Relative Return to S&P 500(%) | -10.99 | | | | | |
Rainer M Erdtmann Ownership Network
Rainer M Erdtmann Owned Company Details
What does Summit Therapeutics Inc do?
Who are the key executives at Summit Therapeutics Inc?
Rainer M Erdtmann is the director of Summit Therapeutics Inc. Other key executives at Summit Therapeutics Inc include Chief Financial Officer Ankur Dhingra , director & 10 percent owner & See Remarks Robert W Duggan , and VP & Corporate Controller Jeffrey R Maranian .
Summit Therapeutics Inc (SMMT) Insider Trades Summary
Over the past 18 months, Rainer M Erdtmann made no insider transaction in Summit Therapeutics Inc (SMMT). Other recent insider transactions involving Summit Therapeutics Inc (SMMT) include a net purchase of 47,169,409 shares made by Maky Zanganeh , a net purchase of 316,762 shares made by Ankur Dhingra , and a net purchase of 376,489,880 shares made by Robert W Duggan .
In summary, during the past 3 months, insiders sold 0 shares of Summit Therapeutics Inc (SMMT) in total and bought 210,321 shares, with a net purchase of 210,321 shares. During the past 18 months, 0 shares of Summit Therapeutics Inc (SMMT) were sold and 426,952,241 shares were bought by its insiders, resulting in a net purchase of 426,952,241 shares.
Summit Therapeutics Inc (SMMT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Summit Therapeutics Inc Insider Transactions
Rainer M Erdtmann Mailing Address
Above is the net worth, insider trading, and ownership report for Rainer M Erdtmann. You might contact Rainer M Erdtmann via mailing address: 1073 Arlington Blvd., El Cerrito Ca 94530.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
